Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
China says no unusual pathogens found after WHO queries respiratory outbreaks
Post Content Post Views: 111
Air strikes and lentil soup: life grinds on in wartime Gaza
Post Content Post Views: 113
Bank Indonesia to maintain key rate at 6.00% until at least mid-2024: Reuters poll
Post Content Post Views: 112
Ford scales back Michigan battery plant, restarts construction
Post Content Post Views: 102
Ousted OpenAI head Sam Altman to lead Microsoft’s new AI team
Former OpenAI CEO Sam Altman will be joining Microsoft to lead a new advanced AI research team, according to Microsoft CEO Satya Nadella. Post Views: 120
Horizons Active Corporate Bond ETF declares CAD 0.032 dividend
Post Content Post Views: 108